Search clinical trials for: Tiotropium Respimat
Total 455 results
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Chile, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Russian Federation, Slovakia, Spain, Ukraine
-
Boehringer IngelheimCompletedCystic FibrosisUnited States, Australia, Austria, Belgium, Canada, Czech Republic, France, Germany, Hungary, Ireland, Israel, Italy, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, Switzerland, United Kingdom
-
Erasme University HospitalCompletedPulmonary Disease, Chronic ObstructiveBelgium
-
Boehringer IngelheimPfizerCompleted
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveGermany, Italy, Switzerland, South Africa
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Austria, Canada, Germany, Netherlands, Russian Federation, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Germany, Italy, New Zealand
-
Imperial College LondonBoehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveChina
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveCanada, United States
-
Lundquist Institute for Biomedical Innovation at...Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Brazil, China, Guatemala, India, Japan, Latvia, Mexico, Peru, Poland, Russian Federation
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Denmark, Germany, Hungary, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Canada, Finland, France, Germany, Hungary, Italy, Spain, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Guatemala, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian... and more
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Brazil, China, Colombia, Germany, India, Japan, Mexico, Peru, Poland, Romania
-
University of DundeeCompleted
-
3MQuotient ClinicalCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Brazil, Canada, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italy, Korea, Republic of, Lithuania, Malaysia, Mexico, Netherlands, Norway, Portugal, Singapore, Slovakia, South... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Brazil, Canada, China, Colombia, Croatia, Germany, Hungary, India, Ireland, Japan, Norway, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, Netherlands, Sweden
-
Duke UniversityWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany
-
3MCompleted
-
3MSimbec ResearchCompleted
-
3MQuotient ClinicalCompleted
-
Boehringer IngelheimCompletedCystic FibrosisUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, New Zealand, Portugal, Russian Federation, United Kingdom
-
University of SaskatchewanCompleted
-
Boehringer IngelheimCompleted
-
University of CreteCompletedChronic Obstructive Pulmonary Disease
-
Verona Pharma plcCompletedCOPDUnited States, United Kingdom
-
Irmandade Santa Casa de Misericórdia de Porto AlegreNovartisCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Maastricht University Medical CenterAstraZeneca; Center for Integrated Rehabilitation and Organ Failure HornUnknownChronic Obstructive Airway DiseaseNetherlands
-
National University of MalaysiaCompletedChronic Obstructive Pulmonary DiseaseMalaysia
-
Novartis PharmaceuticalsWithdrawnPulmonary Disease, Chronic Obstructive
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveKorea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveJapan
-
University of SaskatchewanCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGreece
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic ObstructiveSwitzerland